Editors' Note: Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
For patients with refractory status epilepticus (RSE), international guidelines recommend 24–48 hours of intravenous anesthesia to abort clinical or electrographic seizures. However, the EEG patterns consistent with cessation of RSE are ill-defined. In the analysis by Fisch et al., the investigators retrospectively analyzed clinical and EEG data for 147 patients to determine the incidence rate of induced burst suppression and long-term functional outcome measures and survival. Any burst suppression pattern for patients without anoxic brain injury was achieved in 34% of patients, but this EEG outcome was not associated with persistent seizure termination, in-hospital survival, or return to premorbid level of function. Moreover, any burst suppression pattern was associated with longer length of intensive care unit stay, invasive mechanical ventilation duration, and cumulative hospital stay. The investigators conclude and Dr. Sethi agrees that emphasis should be placed on treating the patient and not the EEG. In a subgroup of patients with anoxic brain injury (n = 45), patients who achieved a higher degree of burst suppression had an incrementally higher odds of seizure termination and in-hospital survival. The investigators suggest these results be interpreted with caution because of the small sample size, inability to adjust for residual confounding, and influence of the “self-fulfilling prophecy” inherent to postarrest neuroprognostication and decision-making.
For patients with refractory status epilepticus (RSE), international guidelines recommend 24–48 hours of intravenous anesthesia to abort clinical or electrographic seizures. However, the EEG patterns consistent with cessation of RSE are ill-defined. In the analysis by Fisch et al., the investigators retrospectively analyzed clinical and EEG data for 147 patients to determine the incidence rate of induced burst suppression and long-term functional outcome measures and survival. Any burst suppression pattern for patients without anoxic brain injury was achieved in 34% of patients, but this EEG outcome was not associated with persistent seizure termination, in-hospital survival, or return to premorbid level of function. Moreover, any burst suppression pattern was associated with longer length of intensive care unit stay, invasive mechanical ventilation duration, and cumulative hospital stay. The investigators conclude and Dr. Sethi agrees that emphasis should be placed on treating the patient and not the EEG. In a subgroup of patients with anoxic brain injury (n = 45), patients who achieved a higher degree of burst suppression had an incrementally higher odds of seizure termination and in-hospital survival. The investigators suggest these results be interpreted with caution because of the small sample size, inability to adjust for residual confounding, and influence of the “self-fulfilling prophecy” inherent to postarrest neuroprognostication and decision-making.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.